Up Against the Big Guys
Local ‘Seoul’: Epirus Approach to Biosimilars Is Portable, Simple
By Randy Osborne
Friday, August 30, 2013
Start-up Epirus Biopharmaceuticals Inc.’s in-market, for-market approach to making and selling biosimilars in emerging territories could be just the “David” ticket to beat pharma Goliaths that dominate the realm, said Amit Munshi, president and CEO of the Boston-based firm.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.